AIM
CBAY

Assured Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

Assured Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-15,717
Closed -$209K – 937
2019
Q1 		$209K Buy
+15,717
New +$167K ﹤0.01% 793
2018
Q3 		– Sell
-7,342
Closed -$99K – 1327
2018
Q2 		$99K Sell
7,342
-76,788
-91% -$961K ﹤0.01% 1083
2018
Q1 		$1.09M Buy
+84,130
New +$1.05M 0.03% 517

Other funds holding CBAY

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

Assured Investment Management's CBAY Position: Q2 2019 in Review

Assured Investment Management sold out of Cymabay Therapeutics (CBAY) in Q2 2019, closing a stake of 15,717 shares — an estimated $209K sold.

Assured Investment Management first reported a position in CBAY in Q1 2018 and held it in 3 quarters. The position peaked at $1.09M in Q1 2018. 133 funds tracked by Wall St. Rank hold CBAY as of Q2 2019.

  • Assured Investment Management reported no remaining Cymabay Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 15,717 Cymabay Therapeutics shares in Q2 2019, an estimated $209K.
  • Assured Investment Management first reported a position in Cymabay Therapeutics in Q1 2018 and held it in 3 quarters.
  • Assured Investment Management's Cymabay Therapeutics position peaked at $1.09M in Q1 2018.
  • 133 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.